
Innovative Research to Advance Oligonucleotide Therapeutics now published in the Journal of Nucleic Acid Therapeutics | Newswise
Newswise — LIMERICK, Pa., Feb. 25, 2025 /PRNewswire/ — Rockland Immunochemicals, Inc. is pleased to announce that Dr. David P. Chimento, Vice President of Research and Development, Amy L. Anderson, Technical Applications Specialist, and Dr. Carl Ascoli, Chief Science Officer, working with Inês Fial, Research Assistant at the Nucleic Acid Therapeutics Accelerator (NATA, Oxford, United Kingdom), have…